Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2010

Open Access 01-12-2010 | Original investigation

Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes

Authors: João S Felício, Ana Carolina CB de Souza, Nárcia Kohlmann, Oswaldo Kohlmann Jr, Arthur B Ribeiro, Maria T Zanella

Published in: Cardiovascular Diabetology | Issue 1/2010

Login to get access

Abstract

Background

Hypertensive patients with reduced blood pressure fall (BPF) at night are at higher risk of cardiovascular events (CVE).

Methods

We evaluated in hypertensive diabetic patients, if a reduced nocturnal BPF can precedes the development of diabetic nephropathy (DN). We followed 70 patients with normal urinary albumin excretion (UAE) for two years. We performed 24-hours ambulatory BP monitoring in baseline and at the end of the study.

Results

Fourteen (20%) patients (GI) developed DN (N = 11) and/or CVE (n = 4). Compared to the remaining 56 patients (GII) in baseline, GI had similar diurnal systolic (SBP) and diastolic BP (DBP), but higher nocturnal SBP (138 ± 15 vs 129 ± 16 mmHg; p < 0.05) and DBP (83 ± 12 vs 75 ± 11 mmHg; p < 0,05). Basal nocturnal SBP correlated with occurrence of DN and CVE (R = 0.26; P < 0.05) and with UAE at the end of the study (r = 0.3; p < 0.05). Basal BPF (%) correlated with final UAE (r = -0.31; p < 0.05). In patients who developed DN, reductions occurred in nocturnal systolic BPF (12 ± 5 vs 3 ± 6%, p < 0,01) and diastolic BPF (15 ± 8 vs 4 ± 10%, p < 0,01) while no changes were observed in diurnal SBP (153 ± 17 vs 156 ± 16 mmHg, NS) and DBP (91 ± 9 vs 90 ± 7 mmHg, NS). Patients with final UAE < 20 μg/min, had no changes in nocturnal and diurnal BP.

Conclusions

Our results suggests that elevations in nocturnal BP precedes DN and increases the risk to develop CVE in hypertensive patients with T2DM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sturrock NDC, George E, Pound N, Stevenson J, Pech GM, Sowter H: Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabetic Medicine. 2000, 17: 360-364. 10.1046/j.1464-5491.2000.00284.x.CrossRefPubMed Sturrock NDC, George E, Pound N, Stevenson J, Pech GM, Sowter H: Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabetic Medicine. 2000, 17: 360-364. 10.1046/j.1464-5491.2000.00284.x.CrossRefPubMed
2.
go back to reference Waugh NR, Dallas JH, Jung RT, Newton RW: Mortality in a cohort of diabetic patients. Diabetologia. 1989, 32: 103-104. 10.1007/BF00505181.CrossRefPubMed Waugh NR, Dallas JH, Jung RT, Newton RW: Mortality in a cohort of diabetic patients. Diabetologia. 1989, 32: 103-104. 10.1007/BF00505181.CrossRefPubMed
3.
go back to reference Farmer CKT, Goldsmit DJA, Quin JD, Dallyn P, Cox J, Kingswood JC, Sharpstone P: Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrology Dialisis Transplant. 1998, 13: 635-639. 10.1093/ndt/13.3.635.CrossRef Farmer CKT, Goldsmit DJA, Quin JD, Dallyn P, Cox J, Kingswood JC, Sharpstone P: Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrology Dialisis Transplant. 1998, 13: 635-639. 10.1093/ndt/13.3.635.CrossRef
4.
go back to reference Verdecchia P, Schillaci G, Gatteshi C, Zampi I, Battisnelli M, Bartoccini C: Blunted Nocturnal Fall in blood pressure in hipertensive women with future cardiovascular morbid events. Circulation. 1993, 88: 986-922.CrossRefPubMed Verdecchia P, Schillaci G, Gatteshi C, Zampi I, Battisnelli M, Bartoccini C: Blunted Nocturnal Fall in blood pressure in hipertensive women with future cardiovascular morbid events. Circulation. 1993, 88: 986-922.CrossRefPubMed
5.
go back to reference Borch-Johnson K, Andersen PK, Deckert T: The effect of proteinuria on the relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985, 28: 590-596. Borch-Johnson K, Andersen PK, Deckert T: The effect of proteinuria on the relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985, 28: 590-596.
6.
go back to reference Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovascular Diabetology. 2006, 5: 19-10.1186/1475-2840-5-19.PubMedCentralCrossRefPubMed Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovascular Diabetology. 2006, 5: 19-10.1186/1475-2840-5-19.PubMedCentralCrossRefPubMed
7.
go back to reference Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Impaired reduction of nocturnal systolic blood pressure and severity of diabetic nephropathy. Exp Clin Cardiol. 2007, 12 (3): 157-160.PubMedCentralPubMed Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Impaired reduction of nocturnal systolic blood pressure and severity of diabetic nephropathy. Exp Clin Cardiol. 2007, 12 (3): 157-160.PubMedCentralPubMed
8.
go back to reference Hansen HP, Rossing P, Tarnow L, Neilsen FS, Jensen BR, Parving HH: Circadian rhythm of arterial pressure and albuminuria in diabetic nephropathy. Kidney Int. 1996, 50: 579-85. 10.1038/ki.1996.352.CrossRefPubMed Hansen HP, Rossing P, Tarnow L, Neilsen FS, Jensen BR, Parving HH: Circadian rhythm of arterial pressure and albuminuria in diabetic nephropathy. Kidney Int. 1996, 50: 579-85. 10.1038/ki.1996.352.CrossRefPubMed
9.
go back to reference Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvares v, Batlle D: Increase in Nocturnal Blood Pressure and Progression to microalbuminuria in Type 1 Diabetes. New England Journal of Medicine. 2002, 347 (11): 797-805. 10.1056/NEJMoa013410.CrossRefPubMed Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvares v, Batlle D: Increase in Nocturnal Blood Pressure and Progression to microalbuminuria in Type 1 Diabetes. New England Journal of Medicine. 2002, 347 (11): 797-805. 10.1056/NEJMoa013410.CrossRefPubMed
10.
go back to reference Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle D: Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension. 1993, 21: 227-35.CrossRefPubMed Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle D: Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension. 1993, 21: 227-35.CrossRefPubMed
11.
go back to reference Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB: Ambulatory blood pressure in type I diabetes mellitus: comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes. 1992, 41: 1035-41. 10.2337/diabetes.41.9.1035.CrossRefPubMed Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB: Ambulatory blood pressure in type I diabetes mellitus: comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes. 1992, 41: 1035-41. 10.2337/diabetes.41.9.1035.CrossRefPubMed
12.
go back to reference Lafferty AR, Werther GA, Clarke CF: Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care. 2000, 23: 533-8. 10.2337/diacare.23.4.533.CrossRefPubMed Lafferty AR, Werther GA, Clarke CF: Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care. 2000, 23: 533-8. 10.2337/diacare.23.4.533.CrossRefPubMed
13.
go back to reference Perloff D, Sokolow M: Ambulatory blood pressure measurements prognostic implications. Arch Malad Coeur Vaissaux. 1991, 84: 221-27. Perloff D, Sokolow M: Ambulatory blood pressure measurements prognostic implications. Arch Malad Coeur Vaissaux. 1991, 84: 221-27.
14.
go back to reference Pecis M, Azevedo MJ, Moraes RS, Ferlin EL, Gross JL: Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care. 2000, 23: 989-93. 10.2337/diacare.23.7.989.CrossRefPubMed Pecis M, Azevedo MJ, Moraes RS, Ferlin EL, Gross JL: Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care. 2000, 23: 989-93. 10.2337/diacare.23.7.989.CrossRefPubMed
15.
go back to reference Poulsen PL, Hansen KW, Mogensen CE: Ambulatory blood pressure in the transition from normo to microalbuminuria: a longitudinal study in IDDM patients. Diabetes. 1994, 43: 1248-53. 10.2337/diabetes.43.10.1248.CrossRefPubMed Poulsen PL, Hansen KW, Mogensen CE: Ambulatory blood pressure in the transition from normo to microalbuminuria: a longitudinal study in IDDM patients. Diabetes. 1994, 43: 1248-53. 10.2337/diabetes.43.10.1248.CrossRefPubMed
16.
go back to reference Morgensen CE, Chacati A, Christensen CK, Close CF, Deckert T, Hommel E: Microalbuminuria: An early marker of renal involvement in Diabetes. Uremia Invest. 1986, 9: 85-95. Morgensen CE, Chacati A, Christensen CK, Close CF, Deckert T, Hommel E: Microalbuminuria: An early marker of renal involvement in Diabetes. Uremia Invest. 1986, 9: 85-95.
17.
go back to reference Felt-Rasmussen B, Borch-Johnsen K, Deckert T, Jensen G, Jenden JS: Microalbuminuria: An important diagnostic tool. Jornal of Diabetes and Its Complications. 1994, 8: 137-145. 10.1016/1056-8727(94)90030-2.CrossRef Felt-Rasmussen B, Borch-Johnsen K, Deckert T, Jensen G, Jenden JS: Microalbuminuria: An important diagnostic tool. Jornal of Diabetes and Its Complications. 1994, 8: 137-145. 10.1016/1056-8727(94)90030-2.CrossRef
18.
go back to reference Morgensen CE, Christian CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984, 31: 189-193. Morgensen CE, Christian CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984, 31: 189-193.
19.
go back to reference Devereaux RB, Reicheck N: Echocardiographic determination of left ventricular mass in man. Autonomic valkidation of method. Circulation. 1997, 55: 613-618.CrossRef Devereaux RB, Reicheck N: Echocardiographic determination of left ventricular mass in man. Autonomic valkidation of method. Circulation. 1997, 55: 613-618.CrossRef
20.
go back to reference Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH: Blood pressure during normal daily activities, sleep, and exercise. JAMA. 1982, 247: 9892-9996. 10.1001/jama.247.7.992.CrossRef Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH: Blood pressure during normal daily activities, sleep, and exercise. JAMA. 1982, 247: 9892-9996. 10.1001/jama.247.7.992.CrossRef
21.
go back to reference Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O: Effects of Losartan and Anlodipine on Urinary Albumin Excretion and Ambulatory Blood Pressure in Hypertensive Type 2 Dibetic Patients With Overt Nephropathy. Diabetes Care. 2005, 08: 1862-68. 10.2337/diacare.28.8.1862.CrossRef Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O: Effects of Losartan and Anlodipine on Urinary Albumin Excretion and Ambulatory Blood Pressure in Hypertensive Type 2 Dibetic Patients With Overt Nephropathy. Diabetes Care. 2005, 08: 1862-68. 10.2337/diacare.28.8.1862.CrossRef
22.
go back to reference Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvares V: The spectrum of circadiam blood pressure changes in type 1 diabetic patients J. Hypertension. 2001, 19: 1421-1428. 10.1097/00004872-200108000-00010.CrossRef Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvares V: The spectrum of circadiam blood pressure changes in type 1 diabetic patients J. Hypertension. 2001, 19: 1421-1428. 10.1097/00004872-200108000-00010.CrossRef
23.
go back to reference Nakano S, Uchida K, Kigoshi T: Circadian rhythm of blood pressure in normotensive NIDDM subjects: its relationship to microvascular complications. Diabetes Care. 1991, 14: 707-805. 10.2337/diacare.14.8.707.CrossRefPubMed Nakano S, Uchida K, Kigoshi T: Circadian rhythm of blood pressure in normotensive NIDDM subjects: its relationship to microvascular complications. Diabetes Care. 1991, 14: 707-805. 10.2337/diacare.14.8.707.CrossRefPubMed
24.
go back to reference Palmas W, Pickering T, Teresi J: Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens. 2008, 10: 12-20. 10.1111/j.1524-6175.2007.07170.x. (Greenwich)CrossRef Palmas W, Pickering T, Teresi J: Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens. 2008, 10: 12-20. 10.1111/j.1524-6175.2007.07170.x. (Greenwich)CrossRef
25.
go back to reference Gambardella S, Frontoni S, Spallone V: Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens. 1993, 6: 97-102.PubMed Gambardella S, Frontoni S, Spallone V: Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens. 1993, 6: 97-102.PubMed
26.
go back to reference Tasali E, Mokhlesi B, Van Cauter E: Obstructive sleep apnea and type 2 Diabetes: interacting epidemics. Chest. 2008, 133: 496-506. 10.1378/chest.07-0828.CrossRefPubMed Tasali E, Mokhlesi B, Van Cauter E: Obstructive sleep apnea and type 2 Diabetes: interacting epidemics. Chest. 2008, 133: 496-506. 10.1378/chest.07-0828.CrossRefPubMed
27.
go back to reference Leitão CB, Canani LH, Silveiro SP, Gross JL: Ambulatory Blood Pressure Monitoring and Type 2 Diabetes Mellitus. Arquivos Brasileiros de Cardiologia. 2007, 89 (5): 347-353. 10.1590/S0066-782X2007001700012.CrossRef Leitão CB, Canani LH, Silveiro SP, Gross JL: Ambulatory Blood Pressure Monitoring and Type 2 Diabetes Mellitus. Arquivos Brasileiros de Cardiologia. 2007, 89 (5): 347-353. 10.1590/S0066-782X2007001700012.CrossRef
28.
go back to reference Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Kohlmann O, Ribeiro AB, Zanella MT: Reproducibility of Ambulatory Blood Pressure Monitoring in Hypertensive Patients with Type 2 Diabetes Mellitus. Arquivos Brasileiros de Cardiologia. 2007, 88 (2): 207-211. 10.1590/S0066-782X2007000200012.CrossRef Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Kohlmann O, Ribeiro AB, Zanella MT: Reproducibility of Ambulatory Blood Pressure Monitoring in Hypertensive Patients with Type 2 Diabetes Mellitus. Arquivos Brasileiros de Cardiologia. 2007, 88 (2): 207-211. 10.1590/S0066-782X2007000200012.CrossRef
29.
go back to reference Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Hoof RV, Amery AK: Mean and range of the abulatory pressure in normotensive subjects from meta-analyzes of 23 studies. Am J Cardiol. 1991, 1: 723-727. 10.1016/0002-9149(91)90529-T.CrossRef Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Hoof RV, Amery AK: Mean and range of the abulatory pressure in normotensive subjects from meta-analyzes of 23 studies. Am J Cardiol. 1991, 1: 723-727. 10.1016/0002-9149(91)90529-T.CrossRef
30.
go back to reference Parati G, Bilo G: Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?. Diabetes Care. 2009, 32: 298-304. 10.2337/dc09-S326.CrossRef Parati G, Bilo G: Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?. Diabetes Care. 2009, 32: 298-304. 10.2337/dc09-S326.CrossRef
31.
go back to reference Belletti DA, Zacher C, Wogen J: Effect of cardiometabolic risk factors on hypertension management: a coss-sectional study among 28 physician in the United States. Cardiovascular Diabetology. 2010, 9: 7-10.1186/1475-2840-9-7.PubMedCentralCrossRefPubMed Belletti DA, Zacher C, Wogen J: Effect of cardiometabolic risk factors on hypertension management: a coss-sectional study among 28 physician in the United States. Cardiovascular Diabetology. 2010, 9: 7-10.1186/1475-2840-9-7.PubMedCentralCrossRefPubMed
Metadata
Title
Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes
Authors
João S Felício
Ana Carolina CB de Souza
Nárcia Kohlmann
Oswaldo Kohlmann Jr
Arthur B Ribeiro
Maria T Zanella
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2010
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-9-36

Other articles of this Issue 1/2010

Cardiovascular Diabetology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.